Currently out of the existing stock ratings of Sean Wieland, 255 are a BUY (76.12%), 65 are a HOLD (19.4%), 15 are a SELL (4.48%).

Sean Wieland

Work Performance Price Targets & Ratings Chart

Analyst Sean Wieland, currently employed carries an average stock price target met ratio of 73.72% that have a potential upside of 29.23% achieved within 227 days. Previously, Sean Wieland worked at PIPER SANDLER.

Sean Wieland’s has documented 695 price targets and ratings displayed on 30 stocks. The coverage was on Healthcare, Technology, Consumer Defensive sectors.

Most recent stock forecast was given on DOCS, Doximity at 10-Nov-2023.

Wall Street Analyst Sean Wieland

Analyst best performing recommendations are on HIMS (HIMS HERS HEALTH).
The best stock recommendation documented was for PHR (PHREESIA) at 12/9/2020. The price target of $56 was fulfilled within 1 day with a profit of $3.39 (6.44%) receiving and performance score of 64.44.

Average potential price target upside

of $40.54 (41.39%) on UNH (UNITEDHEALTH GROUP ORPORATED).
of $34.71 (27.6%) on ATHN (ATHENAHEALTH).
of $13.31 (21.7%) on CERN (CERNER CORP).

AMWL American Well Corp ATHN athenahealth BNFT Benefitfocus CHNG Change Healthcare EVH Evolent Health HCAT Health Catalyst HIMS Hims Hers Health INOV Inovalon Holdings IQV IQVIA Holdings LVGO Livongo Health MDRX Allscripts Healthcare Solutions NXGN Nextgen Healthcare OMCL Omnicell ONE OneSmart International Education Group ONEM 1Life Healthcare OSH Oak Street Health PHR Phreesia PRVA Privia Health Group SGFY Signify Health TDOC Teladoc TRHC Tabula Rasa HealthCare TVTY Tivity Health VCRA Vocera Communications CERN Cerner Corp UNH UnitedHealth Group orporated CPSI Computer Programs and Systems CTLT Catalent DOCS Doximity MDSO Medidata Solutions PINC Premier

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Craig Hettenbach (MORGAN STANLEY)